PET scan to check lymph nodes after breast cancer treatment
Part of Cancer, Skin clinical trials.
This study uses a special PET scan (68Ga FAPI) to check if lymph nodes under the arm still have cancer after you finish pre-surgery treatment. It helps doctors see how well the treatment worked before you have surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- Breast cancer has been confirmed by a biopsy.
- Cancer cells are found in lymph nodes under your arm (clinically positive).
- You have completed at least 3 rounds of pre-surgery treatment (neoadjuvant therapy).
- You are scheduled to have surgery and are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether taking a sample from the sentinel lymph node (a first lymph node that can be involved) improves care compared with observation, after a breast cancer PET scan of the armpit area. It may help people with certain early breast cancers avoid unnecessary procedures if the lymph nodes look negative on scans.
This study tests a new kind of PET/CT scan that uses a tracer called 18F-FAPI to see if it can better detect cancer in the lymph nodes under the arm after you've already had chemotherapy or targeted therapy before surgery. If successful, this could help doctors plan more precise surgery and avoid removing unnecessary lymph nodes.
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
This trial tests a new imaging test (a special PET scan) that can see HER2 proteins in breast cancer tumors. It is for people who are already getting treatment before surgery to see if the scan helps doctors understand how well the therapy is working.
This trial tests a special PET scan (F-FAPI PET) to image metastatic invasive lobular breast cancer. It aims to see if this scan gives a clearer picture than the standard PET scan, helping doctors track the cancer better.
This early study tests a special PET scan (a type of imaging) to look at newly diagnosed ER-positive breast cancer. The goal is to see how well the scan can detect and measure cancer, which may help guide care.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.